October 3, 2008 (Salt Lake City, Utah) — Baroreflex failure following chemotherapy is an underrecognized cause of labile blood pressures, resulting in hypertension, orthostatic hypotension, and ...
The study of the various components of SAP and RR-interval oscillations was conducted at rest and during tilting in a 67-year-old woman with known baroreflex failure. The clinical aspects of the case ...
SAN DIEGO, CA — In a small trial of patients with heart failure and reduced ejection fraction (HF-REF), those who were implanted with the Barostim neo (CVRx) device, which stimulates baroreceptors in ...
Washington, DC — Despite a steady stream of health advisories, younger Americans continue to light up in bars and restaurants. What many do not realize is that tobacco and alcohol combined contributes ...
Patients with throat problems were less able to regulate their blood pressure in a new study led by the University of Southampton. The study published in JAMA Otolaryngology is the first to observe ...
Results of a clinical trial announced today at the American College of Cardiology Annual Scientific Session show a new type of therapy is safe and effective for symptomatic advanced heart failure ...
Cerebral pressure passivity (CPP) in sick newborns can be detected by evaluating coupling between mean arterial pressure (MAP) and cerebral blood flow measured by near infra-red spectroscopy ...
Researchers describe a newly observed phenomenon in the way blood pressure is maintained in certain rats. High blood pressure: some people take medication to control it while others commit to low salt ...
Factors Associated with Survival-to-Discharge in Patients with High-Risk Pulmonary Embolism Requiring Extracorporeal Membrane Oxygenation Receive the the latest news, research, and presentations from ...
It's not officially confirmed but this study supports the notion that this therapy can reduce hospitalizations and the number of days hospitalized. Heart failure is a condition in which the heart ...
A new type of therapy is safe and effective for symptomatic advanced heart failure patients who are already receiving optimum drug and device therapy, a recent study shows. Results of a clinical trial ...
SAN DIEGO - Results of a clinical trial announced today at the American College of Cardiology Annual Scientific Session show a new type of therapy is safe and effective for symptomatic advanced heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback